Abstract
Background The 25-Question Geriatric Locomotive Function Scale (GLFS-25) is one of the tests used to assess the risk of locomotive syndrome (LS). It is a comprehensive tool to measure LS improvement after total hip arthroplasty (THA) and provides beneficial information for rehabilitation after THA. This study aims to investigate the effectiveness of LS improvement three months after THA in patients who underwent THA for hip osteoarthritis (OA) by using the total clinical decision limits (CDL) 3-stage scale to identify specific trends in LS improvement based on the GLFS-25.
Methods The participants of this study were 273 patients who underwent primary THA for hip OA. LS was evaluated using the stand-up test, two-step test, and GLFS-25 before receiving THA and three months after THA.
Results The total CDL was improved by THA in 132 patients (improvement rate: 48.4%). There were 15 questions out of 25 in the GLFS-25 showed improvements in more than 60% of the patients. The question Q13, “To what extent has it been difficult to walk briskly?” revealed the highest improvement rate, followed by Q12, “To what extent has it been difficult to go up and down stairs?”, and Q3, “Did you have any pain (including numbness) in your lower limbs?”.
Conclusions At three months after THA, approximately half of the patients showed improvement in LS. Furthermore, improvement in locomotion movements was identified as the most significant area of progress among motor functions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This before-after comparative study was approved by the Research Ethics Committee of the University of Miyazaki, School of Medicine (Approval No. O-0783). It was carried out in compliance with the Ethical Guidelines for Medical and Biological Research Involving Human Subjects at the Department of Rehabilitation Medicine, University of Miyazaki Affiliated Hospital. The participants of this study were patients who underwent primary THA for hip OA between October 2018 and May 2024. Approval for this study was obtained from the Research Ethics Committee in September 2020. Therefore, data collected before obtaining approval from the Research Ethics Committee were categorized as a retrospective study, while data collected after obtaining approval were categorized as a prospective study. All data used in the retrospective study were fully anonymized prior to access. As it was not feasible to contact participants in the retrospective study and because the information was initially collected for clinical purposes, the opt-out method was applied in accordance with ethical guidelines. Information regarding the conduct of the research including the objectives was disclosed and the research participants were provided an opportunity to refuse inclusion in the research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
